Let’s join our effort in fight against Cancer
Shifa Cancer Hope (SCH) a charity initiative led by Dr. Muhammad Ayaz Mir (Chief of Oncology and Hematology and Bone Marrow Transplant Consultant @ Shifa International Hospital) in collaboration with Shifa Foundation in Pakistan. This initiative aims to ensure that the most expensive cancer treatments is affordable for currently non-affording patients. To accomplish this mission, SCH has defined 2 strategies:
- In Pakistan, the medicines for cancer treatment are beyond the buying capacity of even middle-income patients. SCH is advocating with the pharma industries to reduce the prices of medicines for cancer treatment. Simultaneously, SCH through its crowdfunding supports the medication cost of deserving patients.
- Shifa Foundation’s registered patients are not charged at the Shifa International Hospitals, Ltd. for specialist consultancy fee both in OPD and IPD, nursing fee, Medical Officer fee, and anesthetist fee. Highly subsidized rates are charged for the diagnostics services, OT, wards, and surgical and medical supplies, and medicines. These significant discounts on treatment charges enable Shifa Foundation to support a large number of patients with limited funds.
SCH observes two criteria for patient selection. The medical criterion warrants the patient to be in a productive age and also having a high probability of survival after the treatment. The second component is the financial eligibility. This is done by the Shifa Foundation’s trained staff who also ensure Shariah compliance in Zakaat handling both with donors and patients.
Despite the above measures to reduce the cost of cancer treatment by SCH and Shifa Foundation, the remaining cost still remains beyond the affordability of majority of cancer patients. SCH’s effort to cure and save a cancer patient depends on your generous support through crowdfunding.
This year, Under SCH program, 20 Allogeneic Stem Cell Transplant/ Hematopoietic Cell Transplants will be conducted by the Oncology department of Shifa International Hospital. Through SCH Platform, patients will be treated with blood-related diseases like non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma, and leukemia. These transplants through the SCH subsidized system will cost USD$15,000 for each patient. Furthermore, SCH Program has set a target to conduct 20 Autologous Stem Cell Transplants this year. Each transplant will cost around USD$20,000 through SCH. Together we can save at least 40 lives.
Cancer is dreadful and expensive but together we can alleviate the suffering by supporting their treatment and save many precious lives.